Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL Title Category Date Recent Activity
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/ustekinumab-dispensing-patterns-descriptive-analysis Ustekinumab Dispensing Patterns: A Descriptive Analysis Analyses 11/24/2020
Ustekinumab Dispensing Patterns: A Descriptive Analysis
Analyses 11/24/2020
https://sentinelinitiative.org/methods-data-tools/sentinel-national-resource/patient-characteristics-and-utilization-patterns Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product 01/30/2021
Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product
01/30/2021
https://sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation COVID-19 Pregnancy Study Implementation Methods, Data, & Tools 02/24/2021
COVID-19 Pregnancy Study Implementation
Methods, Data, & Tools 02/24/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/pregnancy-among-women-heart-failure-descriptive-analysis Pregnancy among Women with Heart Failure: A Descriptive Analysis Modular Programs 03/07/2021
Pregnancy among Women with Heart Failure: A Descriptive Analysis
Modular Programs 03/07/2021
https://sentinelinitiative.org/methods-data-tools/sentinel-national-resource/identifying-prescribing-cascades-alzheimers-disease Identifying Prescribing Cascades in Alzheimer's Disease and Related Dementias: The Calcium Channel Blocker-Diuretic Prescribing Cascade 03/14/2021
Identifying Prescribing Cascades in Alzheimer's Disease and Related Dementias: The Calcium Channel Blocker-Diuretic Prescribing Cascade
03/14/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/venous-and-arterial-thromboembolism-among-new-users-nuvaring Venous and Arterial Thromboembolism among New Users of NuvaRing and Other Combined Hormonal Contraceptives: A Descriptive Analysis Modular Programs 03/25/2021
Venous and Arterial Thromboembolism among New Users of NuvaRing and Other Combined Hormonal Contraceptives: A Descriptive Analysis
Modular Programs 03/25/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/lymphoma-risk-following-guselkumab-risankizumab-or Lymphoma Risk following Guselkumab, Risankizumab, or Tildrakizumab Use: A Descriptive Analysis Modular Programs 03/30/2021
Lymphoma Risk following Guselkumab, Risankizumab, or Tildrakizumab Use: A Descriptive Analysis
Modular Programs 03/30/2021
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/adbry-tralokinumab Assessment of ARIA Sufficiency: Adbry (tralokinumab) Sufficiency Assessments 04/08/2021
Assessment of ARIA Sufficiency: Adbry (tralokinumab)
Sufficiency Assessments 04/08/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2016 Duration of Follow Up for New Molecular Entities Approved in 2016 Analyses 04/16/2021
Duration of Follow Up for New Molecular Entities Approved in 2016
Analyses 04/16/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2014-and Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015 Analyses 04/16/2021
Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015
Analyses 04/16/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2010-2012 Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013 Analyses 04/16/2021
Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013
Analyses 04/16/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2008-and Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009 Analyses 04/16/2021
Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009
Analyses 04/16/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2005-2006 Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007 Analyses 04/16/2021
Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007
Analyses 04/16/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2011 Duration of Follow Up for New Molecular Entities Approved in 2011 Analyses 04/16/2021
Duration of Follow Up for New Molecular Entities Approved in 2011
Analyses 04/16/2021
https://sentinelinitiative.org/news-events/publications-presentations/utilization-hydroxyprogesterone-caproate-among-pregnancies Utilization of Hydroxyprogesterone Caproate among Pregnancies with Live Birth Deliveries in the Sentinel Distributed Database Publications and Presentations 04/29/2021
Utilization of Hydroxyprogesterone Caproate among Pregnancies with Live Birth Deliveries in the Sentinel Distributed Database
Publications and Presentations 04/29/2021
https://sentinelinitiative.org/methods-data-tools/methods/treescan-pregnancy TreeScan in Pregnancy Methods, Data, & Tools 07/14/2021
TreeScan in Pregnancy
Methods, Data, & Tools 07/14/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017 Duration of Follow Up for New Molecular Entities Approved in 2017: A Descriptive Analysis Analyses 08/13/2021
Duration of Follow Up for New Molecular Entities Approved in 2017: A Descriptive Analysis
Analyses 08/13/2021
https://sentinelinitiative.org/methods-data-tools/sentinel-national-resource/bbcic-research-network-analysis-first-cycle BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated with High Neutropenia Risk Chemotherapy 08/16/2021
BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated with High Neutropenia Risk Chemotherapy
08/16/2021
https://sentinelinitiative.org/news-events/publications-presentations/use-mobile-app-capture-supplemental-health-information-0 Use of a Mobile App to Capture Supplemental Health Information During Pregnancy: Implications for Clinical Research Publications and Presentations 08/23/2021
Use of a Mobile App to Capture Supplemental Health Information During Pregnancy: Implications for Clinical Research
Publications and Presentations 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/no-differential-risk-cutaneous-small-vessel-vasculitis-oral No Differential Risk of Cutaneous Small Vessel Vasculitis with Oral Anticoagulant Use Among Patients with Atrial Fibrillation Publications and Presentations 08/24/2021
No Differential Risk of Cutaneous Small Vessel Vasculitis with Oral Anticoagulant Use Among Patients with Atrial Fibrillation
Publications and Presentations 08/24/2021
https://sentinelinitiative.org/methods-data-tools/software-packages-toolkits/making-medicaid-data-more-accessible-through-common Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools 09/24/2021
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs
Methods, Data, & Tools 09/24/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-multiple-sclerosis-drugs-among-pregnant-women-live-birth Use of Multiple Sclerosis Drugs Among Pregnant Women with Live-Birth Deliveries: A Descriptive Analysis Assessments 10/20/2021
Use of Multiple Sclerosis Drugs Among Pregnant Women with Live-Birth Deliveries: A Descriptive Analysis
Assessments 10/20/2021
https://sentinelinitiative.org/news-events/publications-presentations/reliable-insights-regarding-medication-outcomes-real-world Reliable Insights Regarding Medication Outcomes From Real World Data – Key Principles of an Evidence Generation Framework Publications and Presentations 11/01/2021
Reliable Insights Regarding Medication Outcomes From Real World Data – Key Principles of an Evidence Generation Framework
Publications and Presentations 11/01/2021
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-community-building-and-outreach-center 2022 Sentinel Community Building and Outreach Center Webinar Series Sentinel Initiative Events 11/23/2021
2022 Sentinel Community Building and Outreach Center Webinar Series
Sentinel Initiative Events 11/23/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-and-hospitalized-depression-following Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis Analyses 12/15/2021
Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis
Analyses 12/15/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-and-hospitalized-depression-0 Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis (A Follow-up to a Previous Analysis) Analyses 12/15/2021
Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis (A Follow-up to a Previous Analysis)
Analyses 12/15/2021
https://sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/data-quality-review-and-characterization-programs Data Quality Review and Characterization Programs Methods, Data, & Tools 12/16/2021
Data Quality Review and Characterization Programs
Methods, Data, & Tools 12/16/2021
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-innovation-and-methods-seminar-series 2022 Sentinel Innovation and Methods Seminar Series Sentinel Initiative Events 01/01/2022
2022 Sentinel Innovation and Methods Seminar Series
Sentinel Initiative Events 01/01/2022
https://sentinelinitiative.org/studies/drugs/zoloft-sertraline-0 Zoloft (Sertraline) & Intentional Self-Harm and Hospitalized Depression Studies 01/04/2022
Zoloft (Sertraline) & Intentional Self-Harm and Hospitalized Depression
Studies 01/04/2022
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/thromboembolic-stroke-algorithm-defined-1 Thromboembolic Stroke Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools 01/06/2022
Thromboembolic Stroke Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools 01/06/2022
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/gastrointestinal-bleeding-algorithm-defined-0 Gastrointestinal Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools 01/06/2022
Gastrointestinal Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools 01/06/2022
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/major-extracranial-bleeding-algorithm-defined-1 Major Extracranial Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools 01/06/2022
Major Extracranial Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools 01/06/2022
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/intracranial-hemorrhage-algorithm-defined-1 Intracranial Hemorrhage Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools 01/06/2022
Intracranial Hemorrhage Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools 01/06/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017-updated Duration of Follow Up for New Molecular Entities Approved in 2017: An Updated Descriptive Analysis Analyses 01/21/2022
Duration of Follow Up for New Molecular Entities Approved in 2017: An Updated Descriptive Analysis
Analyses 01/21/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2019 Duration of Follow Up for New Molecular Entities Approved in 2019: A Descriptive Analysis Analyses 01/26/2022
Duration of Follow Up for New Molecular Entities Approved in 2019: A Descriptive Analysis
Analyses 01/26/2022
https://sentinelinitiative.org/news-events/publications-presentations/evaluating-confounding-control-estimations-influenza-0 Evaluating Confounding Control in Estimations of Influenza Antiviral Effectiveness in Electronic Health Plan Data Publications and Presentations 02/02/2022
Evaluating Confounding Control in Estimations of Influenza Antiviral Effectiveness in Electronic Health Plan Data
Publications and Presentations 02/02/2022
https://sentinelinitiative.org/studies/drugs/prenatal-tests Prenatal Tests & Stillbirth Studies 02/03/2022
Prenatal Tests & Stillbirth
Studies 02/03/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/n-nitrosodimethylamine-ndma-contaminated-and-non-ndma N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis Analyses 02/18/2022
N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis
Analyses 02/18/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/tofacitinib-disease-modifying-anti-rheumatic-drugs-dmards Tofacitinib, Disease-Modifying Anti-Rheumatic Drugs (DMARDs) and Tumor Necrosis Factor Inhibitors (TNFi) Use: A Descriptive Analysis Analyses 02/24/2022
Tofacitinib, Disease-Modifying Anti-Rheumatic Drugs (DMARDs) and Tumor Necrosis Factor Inhibitors (TNFi) Use: A Descriptive Analysis
Analyses 02/24/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/bleeding-events-and-venous-thromboembolism-vte-following Bleeding Events and Venous Thromboembolism (VTE) following Enoxaparin Use: A Descriptive Analysis Analyses 02/25/2022
Bleeding Events and Venous Thromboembolism (VTE) following Enoxaparin Use: A Descriptive Analysis
Analyses 02/25/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-and-prevalence-n-nitrosodimethylamine-ndma-and-n Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis Analyses 03/01/2022
Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis
Analyses 03/01/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/mometasone-furoate-mf-sinus-implant-use-patients-nasal Mometasone Furoate (MF) Sinus Implant Use in Patients with Nasal Polyps: A Descriptive Analysis Analyses 03/03/2022
Mometasone Furoate (MF) Sinus Implant Use in Patients with Nasal Polyps: A Descriptive Analysis
Analyses 03/03/2022
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/vyvgart-efgartigimod-alfa-fcab Assessment of ARIA Sufficiency: Vyvgart (efgartigimod alfa-fcab) Sufficiency Assessments 03/08/2022
Assessment of ARIA Sufficiency: Vyvgart (efgartigimod alfa-fcab)
Sufficiency Assessments 03/08/2022
https://sentinelinitiative.org/methods-data-tools/methods/improving-capture-race-and-ethnicity-data-sentinel Improving Capture of Race and Ethnicity Data in Sentinel Methods, Data, & Tools 03/08/2022
Improving Capture of Race and Ethnicity Data in Sentinel
Methods, Data, & Tools 03/08/2022
https://sentinelinitiative.org/news-events/publications-presentations/cnodes-webinar-surveillance-adverse-infant-outcomes CNODES Webinar: Surveillance of Adverse Infant Outcomes Following Maternal Medication Use During Pregnancy Using Tree-Based Scan Statistics Publications and Presentations 03/09/2022
CNODES Webinar: Surveillance of Adverse Infant Outcomes Following Maternal Medication Use During Pregnancy Using Tree-Based Scan Statistics
Publications and Presentations 03/09/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/human-epidermal-growth-factor-receptor-2-her2-antagonist-use Human Epidermal Growth Factor Receptor 2 (HER2) Antagonist Use in Patients with Live Birth Deliveries: A Descriptive Analysis Analyses 03/11/2022
Human Epidermal Growth Factor Receptor 2 (HER2) Antagonist Use in Patients with Live Birth Deliveries: A Descriptive Analysis
Analyses 03/11/2022
https://sentinelinitiative.org/methods-data-tools/methods/sentinel-innovation-center-request-proposal-feature-engineering Sentinel Innovation Center Request for Proposal: Feature Engineering Methods, Data, & Tools 03/15/2022
Sentinel Innovation Center Request for Proposal: Feature Engineering
Methods, Data, & Tools 03/15/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/incident-and-prevalent-use-loop-diuretics-descriptive Incident and Prevalent Use of Loop Diuretics: A Descriptive Analysis Analyses 03/23/2022
Incident and Prevalent Use of Loop Diuretics: A Descriptive Analysis
Analyses 03/23/2022
https://sentinelinitiative.org/engage-sentinel/quarterly-newsletter Quarterly Newsletter Spotlight 03/24/2022
Quarterly Newsletter
Spotlight 03/24/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/valganciclovir-use-children-congenital-cytomegalovirus Valganciclovir Use in Children with Congenital Cytomegalovirus Disease (cCMV) or Cytomegalovirus (CMV) Infection: A Descriptive Analysis Analyses 03/25/2022
Valganciclovir Use in Children with Congenital Cytomegalovirus Disease (cCMV) or Cytomegalovirus (CMV) Infection: A Descriptive Analysis
Analyses 03/25/2022
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/data-leakage-due-care-provided-outside-study-electronic Data Leakage Due to Care Provided Outside of the Study Electronic Health Record System: Potential Biases and Solutions Sentinel Initiative Events 03/28/2022
Data Leakage Due to Care Provided Outside of the Study Electronic Health Record System: Potential Biases and Solutions
Sentinel Initiative Events 03/28/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/epidiolex-prescription-cannabidiol-utilization-patterns Epidiolex (prescription cannabidiol) Utilization Patterns: A Query Builder Analysis Analyses 03/28/2022
Epidiolex (prescription cannabidiol) Utilization Patterns: A Query Builder Analysis
Analyses 03/28/2022
https://sentinelinitiative.org/news-events/publications-presentations/landscape-analysis-valganciclovir-treatment-congenital A Landscape Analysis of Valganciclovir Treatment for Congenital Cytomegalovirus Infection in the United States (US), 2008-2021 Publications and Presentations 03/28/2022
A Landscape Analysis of Valganciclovir Treatment for Congenital Cytomegalovirus Infection in the United States (US), 2008-2021
Publications and Presentations 03/28/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/hydroxyurea-use-among-patients-sickle-cell-disease-scd Hydroxyurea Use Among Patients with Sickle Cell Disease (SCD): A Descriptive Analysis Analyses 03/29/2022
Hydroxyurea Use Among Patients with Sickle Cell Disease (SCD): A Descriptive Analysis
Analyses 03/29/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/estimated-prevalence-glomerular-diseases-descriptive Estimated Prevalence of Glomerular Diseases: A Descriptive Analysis Analyses 03/29/2022
Estimated Prevalence of Glomerular Diseases: A Descriptive Analysis
Analyses 03/29/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/estimated-prevalence-glomerular-diseases-updated-descriptive Estimated Prevalence of Glomerular Diseases: An Updated Descriptive Analysis Analyses 03/29/2022
Estimated Prevalence of Glomerular Diseases: An Updated Descriptive Analysis
Analyses 03/29/2022
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/saphnelo-anifrolumab-fnia Assessment of ARIA Sufficiency: Saphnelo (anifrolumab fnia) Sufficiency Assessments 04/01/2022
Assessment of ARIA Sufficiency: Saphnelo (anifrolumab fnia)
Sufficiency Assessments 04/01/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-brodalumab-descriptive-analysis Utilization of Brodalumab: A Descriptive Analysis Analyses 04/05/2022
Utilization of Brodalumab: A Descriptive Analysis
Analyses 04/05/2022
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system Sentinel Routine Querying System Methods, Data, & Tools 04/05/2022
Sentinel Routine Querying System
Methods, Data, & Tools 04/05/2022
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system-reporting-tool Sentinel Routine Querying System Reporting Tool Methods, Data, & Tools 04/05/2022
Sentinel Routine Querying System Reporting Tool
Methods, Data, & Tools 04/05/2022
https://sentinelinitiative.org/news-events/publications-presentations/systemic-corticosteroid-use-covid-19-us-outpatient-settings Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021 Publications and Presentations 04/08/2022
Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021
Publications and Presentations 04/08/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-individuals-drug-device Counts and Characteristics of Individuals With Drug-Device Combination Use: A Descriptive Analysis Analyses 04/18/2022
Counts and Characteristics of Individuals With Drug-Device Combination Use: A Descriptive Analysis
Analyses 04/18/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2018 Duration of Follow Up for New Molecular Entities Approved in 2018: A Descriptive Analysis Analyses 04/20/2022
Duration of Follow Up for New Molecular Entities Approved in 2018: A Descriptive Analysis
Analyses 04/20/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-and-prevalence-confounding-variables-over-time Incidence and Prevalence of Confounding Variables Over Time in the Sentinel Distributed Database (SDD): A Descriptive Analysis Analyses 04/21/2022
Incidence and Prevalence of Confounding Variables Over Time in the Sentinel Distributed Database (SDD): A Descriptive Analysis
Analyses 04/21/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/thromboembolic-stroke-major-extracranial-bleeding-0 Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis Analyses 04/25/2022
Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis
Analyses 04/25/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/death-data-exploration-descriptive-analysis Death Data Exploration: A Descriptive Analysis Analyses 04/28/2022
Death Data Exploration: A Descriptive Analysis
Analyses 04/28/2022
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-innovation-day-sentinel-public-training-april-28-29 2022 Innovation Day & Sentinel Public Training, April 28 - 29 Sentinel Initiative Events 04/28/2022
2022 Innovation Day & Sentinel Public Training, April 28 - 29
Sentinel Initiative Events 04/28/2022
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-innovation-day 2022 Sentinel Innovation Day Sentinel Initiative Events 04/28/2022
2022 Sentinel Innovation Day
Sentinel Initiative Events 04/28/2022
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-public-training-day 2022 Sentinel Public Training Day Sentinel Initiative Events 04/29/2022
2022 Sentinel Public Training Day
Sentinel Initiative Events 04/29/2022
https://sentinelinitiative.org/news-events/publications-presentations/use-real-world-data-surveillance-medications-pregnancy Use of Real-World Data for Surveillance of Medications in Pregnancy Publications and Presentations 05/09/2022
Use of Real-World Data for Surveillance of Medications in Pregnancy
Publications and Presentations 05/09/2022
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/can-we-train-machine-learning-methods-outperform-high Can We Train Machine Learning Methods to Outperform the High-Dimensional Propensity Score Algorithm? Sentinel Initiative Events 05/11/2022
Can We Train Machine Learning Methods to Outperform the High-Dimensional Propensity Score Algorithm?
Sentinel Initiative Events 05/11/2022
https://sentinelinitiative.org/studies/drugs/aldactone-spironolactone Aldactone (spironolactone) & Indications for Use Studies 05/16/2022
Aldactone (spironolactone) & Indications for Use
Studies 05/16/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-pediatric-demographics-and-enrollment Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: A Descriptive Analysis Analyses 05/16/2022
Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: A Descriptive Analysis
Analyses 05/16/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/serious-infection-following-ustekinumab-use-patients-crohn-s Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease or Ulcerative Colitis: A Descriptive Analysis Analyses 05/17/2022
Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease or Ulcerative Colitis: A Descriptive Analysis
Analyses 05/17/2022
https://sentinelinitiative.org/news-events/publications-presentations/scalable-algorithm-development-alternative-algorithm-reuse Scalable Algorithm Development: An Alternative to Algorithm Reuse? Publications and Presentations 05/17/2022
Scalable Algorithm Development: An Alternative to Algorithm Reuse?
Publications and Presentations 05/17/2022
https://sentinelinitiative.org/studies/drugs/makena-hydroxyprogesterone-caproate-injection-and-its-generics Makena (Hydroxyprogesterone Caproate Injection) and Its Generics & Use in Pregnancy Studies 05/31/2022
Makena (Hydroxyprogesterone Caproate Injection) and Its Generics & Use in Pregnancy
Studies 05/31/2022
https://sentinelinitiative.org/methods-data-tools/methods/approaches-handling-partially-observed-confounder-data-electronic-health Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes Methods, Data, & Tools 06/01/2022
Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes
Methods, Data, & Tools 06/01/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outpatient-corticosteroid-use-patients-covid-19-descriptive Outpatient Corticosteroid Use in Patients With COVID-19: A Descriptive Analysis Analyses 06/01/2022
Outpatient Corticosteroid Use in Patients With COVID-19: A Descriptive Analysis
Analyses 06/01/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outpatient-corticosteroid-use-patients-covid-19-updated Outpatient Corticosteroid Use in Patients With COVID-19: An Updated Descriptive Analysis Analyses 06/02/2022
Outpatient Corticosteroid Use in Patients With COVID-19: An Updated Descriptive Analysis
Analyses 06/02/2022
https://sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/sentinel-common-data-model Sentinel Common Data Model Methods, Data, & Tools 06/03/2022
Sentinel Common Data Model
Methods, Data, & Tools 06/03/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/bamlanivimab-bamlanivimab-and-etesevimab-and-casirivimab Bamlanivimab, Bamlanivimab and Etesevimab, and Casirivimab-Imdevimab Use in Patients with COVID-19: A Descriptive Analysis Analyses 06/14/2022
Bamlanivimab, Bamlanivimab and Etesevimab, and Casirivimab-Imdevimab Use in Patients with COVID-19: A Descriptive Analysis
Analyses 06/14/2022
https://sentinelinitiative.org/studies/drugs/women-heart-failure Women with Heart Failure & Pregnancy Studies 06/21/2022
Women with Heart Failure & Pregnancy
Studies 06/21/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterizing-pregnant-women-and-without-evidence-heart Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis Analyses 06/21/2022
Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis
Analyses 06/21/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/count-and-duration-follow-new-onset-cancer-updated Count and Duration of Follow up of New Onset Cancer: An Updated Descriptive Analysis Analyses 06/23/2022
Count and Duration of Follow up of New Onset Cancer: An Updated Descriptive Analysis
Analyses 06/23/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/tacrolimus-use-patients-following-liver-or-kidney Tacrolimus Use in Patients Following Liver or Kidney Transplants: A Descriptive Analysis Analyses 06/24/2022
Tacrolimus Use in Patients Following Liver or Kidney Transplants: A Descriptive Analysis
Analyses 06/24/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-monoclonal-antibodies-mabs-under-emergency-use Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: A Descriptive Analysis Analyses 06/24/2022
Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: A Descriptive Analysis
Analyses 06/24/2022